{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-016464","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.886882+00:00","generated_at":"2026-06-15T12:10:39.377890+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ApolloMed Q1 revenue $337M (+28% YoY), EPS $0.31 flat; appoints Chan Basho CFO","bullets":["Q1 revenue $337.2M (+28% YoY), net income attributable $14.6M (+3%), diluted EPS $0.31 (flat YoY).","Adjusted EBITDA $29.8M vs $34.4M, decrease driven by higher investments and non-cash gains.","Chan Basho appointed permanent CFO (was interim); will remain Chief Strategy Officer.","Acquired For Your Benefit (FYB) and received CA DMHC approval for Knox-Keene health plan, enabling global risk assumption.","Reaffirms FY23 guidance: revenue $1.3B-$1.5B, net income $49.5M-$71.5M, adj EBITDA $120M-$160M, EPS $0.95-$1.20."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-016464","json":"https://secwatch.observer/filing/0001628280-23-016464.json","markdown":"https://secwatch.observer/filing/0001628280-23-016464.md","text":"https://secwatch.observer/filing/0001628280-23-016464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/0001628280-23-016464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/ameh-20230505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T12:10:39.377890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"71b0b3e37f00be7e0298fe0e6eb87529defa413b","claim":"Astrana Health, Inc. reported first quarter ended March 31, 2023 results: revenue $337.2 million, net income $14.6 million, EPS $0.31. Guidance reaffirmed.","evidence_excerpt":"Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the first quarter ended March 31, 2023. Financial Highlights for First Quarter Ended March 31, 2023: • Total revenue of $337.2 million, up 28% from $263.3 million for the prior-year quarter • Net income attributable to ApolloMed of $14.6 million, up 3% from $14.3 million for the prior-year quarter • Earnings per share - diluted (“EPS - diluted”) of $0.31, compared to $0.31 per share for the prior-year quarter","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/0001628280-23-016464-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$337.2 million"},{"label":"Net income","value":"$14.6 million"},{"label":"EPS","value":"$0.31"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"cb6c8225a7","claim":"Chan Basho was appointed as Chief Financial Officer at Astrana Health, Inc..","evidence_excerpt":"On May 5, 2023, the Company’s Board of Directors appointed Chan Basho as Chief Financial Officer and principal financial officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/0001628280-23-016464-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}